Andra AP fonden Raises Position in Intuitive Surgical, Inc. $ISRG

Andra AP fonden lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 97.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 32,400 shares of the medical equipment provider’s stock after acquiring an additional 16,000 shares during the quarter. Andra AP fonden’s holdings in Intuitive Surgical were worth $14,490,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in Intuitive Surgical by 0.8% during the 3rd quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock worth $15,026,776,000 after purchasing an additional 263,828 shares during the period. State Street Corp boosted its stake in shares of Intuitive Surgical by 1.2% in the second quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock valued at $8,451,223,000 after buying an additional 182,871 shares in the last quarter. Geode Capital Management LLC grew its holdings in Intuitive Surgical by 1.4% during the second quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock worth $4,429,590,000 after acquiring an additional 109,904 shares during the period. Norges Bank acquired a new position in Intuitive Surgical during the second quarter worth $2,569,260,000. Finally, Invesco Ltd. raised its position in Intuitive Surgical by 4.8% in the second quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock worth $2,402,488,000 after acquiring an additional 201,159 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on ISRG shares. The Goldman Sachs Group reaffirmed a “buy” rating and set a $714.00 price target on shares of Intuitive Surgical in a research note on Friday, January 9th. Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 19th. Evercore dropped their target price on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a report on Friday, January 23rd. BTIG Research reissued a “buy” rating and set a $616.00 price target on shares of Intuitive Surgical in a research note on Friday, January 23rd. Finally, Robert W. Baird dropped their price objective on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research note on Friday, January 23rd. Two research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $615.86.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the sale, the executive vice president directly owned 409 shares of the company’s stock, valued at $202,438.64. The trade was a 50.72% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP Fredrik Widman sold 133 shares of the company’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the sale, the vice president owned 660 shares of the company’s stock, valued at approximately $326,673.60. The trade was a 16.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 56,409 shares of company stock worth $30,895,377 over the last 90 days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 0.7%

Shares of NASDAQ:ISRG opened at $503.51 on Friday. The firm has a market cap of $178.81 billion, a price-to-earnings ratio of 63.82, a PEG ratio of 3.91 and a beta of 1.65. The stock’s 50-day moving average price is $529.83 and its two-hundred day moving average price is $511.48. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same period in the prior year, the firm posted $2.21 EPS. The company’s revenue was up 18.8% on a year-over-year basis. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.